Skip to main content
OpenTrials

Clinical trial condition

Meningococcal Vaccine

Explore clinical trials studying Meningococcal Vaccine. Study availability and eligibility vary by location and protocol.

11 public trials 0 recruiting studies
Refine in advanced search Browse all conditions

Meningococcal Vaccine trial results

Completed

A Trial to Describe the Safety and Immunogenicity of MenABCWY When Administered on 2 Schedules

NCT04440176

Conditions
Meningococcal Vaccine
Locations
  • AMR Clinical Mobile, Alabama, United States
  • California Research Foundation San Diego, California, United States
  • Nona Pediatric Center Orlando, Florida, United States
  • Velocity Clinical Research, Norfolk Norfolk, Nebraska, United States
View all 20 locations
View Trial Details
Completed

Trial to Describe the Safety, Tolerability, and Immunogenicity of Trumenba When Administered to Immunocompromised Participants ≥10 Years of Age

NCT04893811

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +11 more
Locations
  • Fakultni Nemocnice Brno - Detska Nemocnice - Klinika Detskych Infekcnich Nemoci Center 3 Brno, Czechia
  • Fakultni Nemocnice Brno - Detska Nemocnice - Klinika Detskych Infekcnich Nemoci Center 3 Brno, Czechia
  • Fakultni nemocnice v Motole Prague, Czechia
  • IN-VIVO Sp. z o.o. Bydgoszcz, Poland
View all 14 locations
View Trial Details
Completed

Study to Evaluate the Safety and Immunogenicity of Nimenrix (Registered) in Healthy Infants, Given at 3 and 12 Months of Age

NCT04819113

Conditions
Meningococcal Vaccine
Locations
  • Tampere Vaccine Research Clinic Tampere, Pirkanmaa, Finland
  • Jarvenpaa Vaccine Research Center Jarvenpaa, Uusimaa, Finland
  • Espoo Vaccine Research Clinic Espoo, Finland
  • FVR, Etelä-Helsingin rokotetutkimusklinikka Helsinki, Finland
View all 16 locations
View Trial Details
Completed

A Trial to Describe the Immunogenicity and Safety of 2 Doses of Bivalent rLP2086 (Trumenba) and a Pentavalent Meningococcal Vaccine in Healthy Subjects >=10 to <26 Years of Age.

NCT03135834

Conditions
Meningococcal Vaccine
Locations
  • Alabama Clinical Therapeutics, LLC Birmingham, Alabama, United States
  • Optimal Research, LLC Huntsville, Alabama, United States
  • Synexus Clinical Research US, Inc./Fountain Hills Family Practice, P.C. Fountain Hills, Arizona, United States
  • Clinical Research Consortium Tempe, Arizona, United States
View all 75 locations
View Trial Details
Completed

MenABCWY Noninferiority Study in Healthy Participants ≥10 to <26 Years of Age

NCT04440163

Conditions
Meningococcal Vaccine
Locations
  • Alabama Clinical Therapeutics, LLC, Birmington Pediatric Assocaites Birmingham, Alabama, United States
  • Central Research Associates, Inc. Birmingham, Alabama, United States
  • Fiel Family and Sports Medicine, PC/CCT Research Tempe, Arizona, United States
  • Velocity Clinical Research (Banning) Banning, California, United States
View all 78 locations
View Trial Details
Completed

A Trial to Assess the Safety, Tolerability and Immunogenicity of Repevax and rLP2086 Vaccine When Given Together in Healthy Subjects Aged >=11 to <19 Years.

NCT01323270

Conditions
Meningitis, Meningococcal Vaccine, N Meningitidis Serogroup B, +4 more
Locations
  • Espoo Vaccine Research Clinic Espoo, Finland
  • Helsinki South Vaccine Research Clinic Helsinki, Finland
  • Ita-Helsinki Vaccine Research Clinic Helsinki, Finland
  • Järvenpää Vaccine Research Clinic Jarvenpaa, Finland
View all 36 locations
View Trial Details
Completed

A Trial To Assess The Safety, Tolerability, And Immunogenicity Of Rlp2086 Vaccine When Administered In Either 2- Or 3-Dose Regimens In Healthy Subjects Aged ≥11 To <19 Years

NCT01299480

Conditions
Meningococcal Vaccine
Locations
  • Ordinace praktickeho lekare pro deti a dorost Brandýs nad Labem-Stará Boleslav, Czechia
  • Ordinace praktickeho lekare pro deti a dorost Chlumec nad Cidlinou, Czechia
  • Ordinace praktickeho lekare pro deti a dorost Holice, Czechia
  • Ordinace praktickeho lekare pro deti a dorost Hradec Králové, Czechia
View all 63 locations
View Trial Details
Completed

MenB Vaccine: Implementation Via Information, Empowerment and Accessibility

NCT02975596

Conditions
Meningococcal Vaccine
Locations
  • UF Health Family Medicine and Pediatrics - Magnolia Parke Gainesville, Florida, United States
  • UF Health Pediatric After Hours Gainesville, Florida, United States
  • UF Health Pediatrics - Gerold L. Schiebler CMS Center Gainesville, Florida, United States
  • UF Health Pediatrics - Tower Square Gainesville, Florida, United States
View Trial Details

Related conditions